The estimated Net Worth of William R Rohn is at least $3.33 Milion dollars as of 17 November 2004. William Rohn owns over 2,700 units of Sophiris Bio Inc stock worth over $0 and over the last 21 years William sold SPHS stock worth over $3,329,928.
Sign up
William Rohn SPHS stock SEC Form 4 insiders trading
William has made over 14 trades of the Sophiris Bio Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently William sold 2,700 units of SPHS stock worth $157,383 on 17 November 2004.
The largest trade William's ever made was exercising 75,000 units of Sophiris Bio Inc stock on 17 November 2004 worth over $519,000. On average, William trades about 13,315 units every 10 days since 2003. As of 17 November 2004 William still owns at least 65,462 units of Sophiris Bio Inc stock.
You can see the complete history of William Rohn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's William Rohn's mailing address?
William's mailing address filed with the SEC is C/O CERUS CORP, 2411 STENWELL DRIVE, CONCORD, CA, 94520.
Insiders trading at Sophiris Bio Inc
Over the last 11 years, insiders at Sophiris Bio Inc have traded over $592,052 worth of Sophiris Bio Inc stock and bought 1,642,180 units worth $8,144,540 . The most active insiders traders include Capital, Llc Boxer Asset Ma..., Capital, Llc Boxer Asset Ma... a William R Rohn. On average, Sophiris Bio Inc executives and independent directors trade stock every 155 days with the average trade being worth of $0. The most recent stock trade was executed by Randall E Woods on 19 September 2018, trading 10,000 units of SPHS stock currently worth $26,300.
What does Sophiris Bio Inc's logo look like?
Complete history of William Rohn stock trades at Biogen Inc, Cerus, Pfenex a Sophiris Bio Inc
Sophiris Bio Inc executives and stock owners
Sophiris Bio Inc executives and other stock owners filed with the SEC include:
-
Randall Woods,
President, Chief Executive Officer, Director -
Allison Hulme,
Director -
Randall E. Woods,
Pres, CEO & Director -
Peter Slover,
Chief Financial Officer -
Lars Ekman,
Chairman of the Board -
Gerald Proehl,
Independent Director -
John Geltosky,
Independent Director -
Iain R. Mant Esq.,
Corp. Sec. -
Dr. James Joseph Beesley,
Sr. Director of Investor Relations -
Dr. Samuel R. Denmeade M.D.,
Chief Scientific Officer & Member of the Scientific Advisory Board -
James L Heppell,
Director -
Joseph L Turner,
Director -
Capital, Llc Boxer Asset Ma...,
-
William R Rohn,
Director -
Capital, Llc Boxer Asset Ma...,